Sign inJoin waitlistJoin the waitlist

Jeremy Rudnick

Physician · Torrance Memorial Medical Center

Credentials: · · ·

History

Torrance Memorial Medical Center
Present

New York Presbyterian Hospital
2025–2026
Memorial Sloan Kettering Cancer Center
2003–2006
SUNY Downstate Medical Center
2002–2003
Doctor of Medicine
1998–2002

Research

Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
Cancer immunology · 2013 · 303 citations
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
Science Translational Medicine · 2019 · 235 citations
Atypical and anaplastic meningiomas treated with bevacizumab
Journal of Neuro-Oncology · 2012 · 150 citations

Jethro Hu
12 papers · 2 as a fellow
John Yu
7 papers
Keith Black
7 papers
Chirag Patil
5 papers
Ray Chu
5 papers
SP
Surasak Phuphanich
5 papers
Serguei Bannykh
4 papers
Xuemo Fan
4 papers
Santosh Kesari
3 papers
Adam Mamelak
2 papers
Clark Chen
2 papers · 1 as a fellow
David Piccioni
2 papers

Clinical trials

Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma
Principal investigator · Withdrawn · Phase 1
Jeremy Rudnick, M.D
2026–2027
Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
Principal investigator · Unknown · Phase 1
TransMolecular
2008–2010
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
Site PI · Recruiting · Phase 2
ECOG-ACRIN Cancer Research Group
2024–2027
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Site PI · Recruiting · Phase 2
Alliance for Clinical Trials in Oncology
2015–2028